Panadol
APP2021: Annalee Combis talks about the latest trends in the VMS category
Over the past year, Australians are increasingly seeking for more holistic solutions for their wellness needs. In this interview, Annalee Combis, Marketing Lead – Wellness at GSK Consumer Healthcare talks to Miranda Deakin on the latest buyer trends in the VMS …
APP2021: James Meins talks about the growth opportunity in the pain category
The 2021 Panadol Care Study found Australians are feeling more physical pain than before, particularly among the younger generations. James Meins, Senior Marketing Manager at GSK Consumer Healthcare joined Miranda Deakin on stage at …
APP2021: Professor David Hunter on how pharmacists can facilitate more positive OA management outcomes
Osteoarthritis (OA) is a leading cause of disability that affects more than 3 million Australians. At APP 2021, Professor David Hunter, Florance and Cope Chair of Rheumatology, Professor of Medicine, the University of Sydney spoke …
APP2021: Anish Patel on the role pharmacists play to deliver better healthcare outcomes
At the helm of GSK Consumer Healthcare in Australia and New Zealand is Area General Manager Anish Patel. In this interview with Miranda Deakin at APP2021, he talks about his passion for leading the team at …
A lot of pain
Pharmacy still leads supermarkets as the preferred source of pain medication, with one in seven choosing CWH New data has revealed that pharmacy is still the primary source of pain …
Children’s Panadol recall
GlaxoSmithKline is recalling three batches of Children’s Panadol due to possible contamination, the TGA has confirmed. The recall involves two batches of Children’s Panadol 5-12 Suspension Strawberry (200mL) and one …